Front Page

Top Pharma, Biotech Cos Keen To Outsource $200 M Research PRACHI VERMA New Delhi:   After infotech firms, it’s the turn of biotech and pharma companies to look at outsourcing from India. According to Proximare Inc, a consultant for pharma and related companies, over $200-million worth work is likely to be outsourced from India over the next 12 months in the field of biotechnology and pharmaceuticals. “There are around 10 biotech and pharma companies (clients) that are considering outsourcing their work to India through partners or starting a greenfield project. Around $200 million work in pharma and related areas is likely to be outsourced to India in the next 12 months,” Proximare managing director Nailesh A Bhatt told eFE. These companies that are looking at India for outsourcing are in the $50 million to $1 billion-plus category in terms of revenues, he said. “These companies are mostly looking at collaborative research outsourcing work to be done out of India. This work has immense opportunity for the Indian talent pool,” Mr Bhatt said. Proximare Inc specialises in helping pharmaceuticals, biotech, medical products and related companies design and implement business strategies. The list of companies considering to outsource work to India include small to mid-sized pharma companies and biotech companies besides major pharma companies. Some of Proximare’s clients include Merck, Bristol-Myers, Squibb, Warner-Lambert, Colgate-Palmolive, Sumitomo, InnoCentive and Pfizer. “Most of our existing clients are keen on setting up research and development (R&D) work in India,” he said. Proximare works with its clients to develop innovative solutions on issues ranging from sales, marketing to strategy and business development and R&D. The company focuses on sectors like pharmaceuticals, biotechnology, medical products, chemical, food, nutraceutical, cosmetics and e-health. Collaborative research outsourcing (CRO) is likely to become the next big wave after contract research outsourcing, Mr Bhatt said. According to a report on clinical research by the Confederation of Indian Industry (CII), the contract research service market is estimated to be around $9 billion. “There is an increased global trend towards collaborative outsourcing,” the CII report says. The global outsourcing pre-clinical work and clinical research accounts for nearly $13 billion.

URL: http://www.financialexpress.com/fe_full_story.php?content_id=47861 Print this Story Expressindia | The Indian Express | The Financial Express | Screen | Kashmir Live About Us | Advertise With Us | Privacy Policy | | Labelled with ICRA © 2005: Indian Express Newspapers (Bombay) Ltd. All rights reserved throughout the world. Top | Close this window